<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain><z:chebi fb="0" ids="7939">Parthenolide</z:chebi> (PT), a principal active component in medicinal plants, has been used conventionally to treat <z:hpo ids='HP_0002076'>migraine</z:hpo> and <z:mp ids='MP_0001845'>inflammation</z:mp> </plain></SENT>
<SENT sid="1" pm="."><plain>This component has recently been reported to induce <z:mpath ids='MPATH_3'>apoptosis</z:mpath> in <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancer</z:e> cells, through <z:hpo ids='HP_0001427'>mitochondrial</z:hpo> dysfunction </plain></SENT>
<SENT sid="2" pm="."><plain>In the present study, we investigated PT-mediated cell <z:hpo ids='HP_0011420'>death</z:hpo> signaling pathway by focusing on the involvement of Bcl-2 family members in human <z:e sem="disease" ids="C1527249,C0009402" disease_type="Neoplastic Process" abbrv="">colorectal cancer</z:e> cells </plain></SENT>
<SENT sid="3" pm="."><plain>We also investigated the inhibitory effect of PT on <z:e sem="disease" ids="C0598934" disease_type="Neoplastic Process" abbrv="">tumor growth</z:e> in xenografts </plain></SENT>
<SENT sid="4" pm="."><plain>Using the human <z:e sem="disease" ids="C1527249,C0009402" disease_type="Neoplastic Process" abbrv="">colorectal cancer</z:e> cell lines HT-29, SW620 and LS174T, we demonstrated that treatment of these <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancer</z:e> cells with PT induces <z:mpath ids='MPATH_3'>apoptosis</z:mpath> using <z:chebi fb="0" ids="53233">MTT</z:chebi>, Annexin V assay and Hoechst 33258 staining </plain></SENT>
<SENT sid="5" pm="."><plain><z:mpath ids='MPATH_3'>Apoptosis</z:mpath> through the <z:hpo ids='HP_0001427'>mitochondrial</z:hpo> pathway was confirmed by detecting regulation of Bcl-2 family members, <z:chebi fb="0" ids="4056">cytochrome</z:chebi> c release and caspase activation </plain></SENT>
<SENT sid="6" pm="."><plain>Moreover, intraperitoneal injection of PT showed significant inhibition of <z:e sem="disease" ids="C0598934" disease_type="Neoplastic Process" abbrv="">tumor growth</z:e>, <z:mpath ids='MPATH_177'>angiogenesis</z:mpath> in the <z:e sem="disease" ids="C1520166" disease_type="Experimental Model of Disease" abbrv="">xenograft model</z:e> </plain></SENT>
<SENT sid="7" pm="."><plain>These results demonstrate that PT exhibits anti-<z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancer</z:e> activity in human <z:e sem="disease" ids="C1527249,C0009402" disease_type="Neoplastic Process" abbrv="">colorectal cancer</z:e> in vitro and in vivo </plain></SENT>
<SENT sid="8" pm="."><plain>These findings may also provide a novel approach for the treatment of <z:e sem="disease" ids="C1527249,C0009402" disease_type="Neoplastic Process" abbrv="">colorectal cancer</z:e> </plain></SENT>
</text></document>